Clinical Trial Update: Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase I study evaluating endovenous administration of the oncolytic adenovirus ICOVIR-5 in patients with locally advanced or metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ICOVIR-5 (ICOVIR-5)

Snippet

Sponsor: Institut Català d'Oncologia | Conditions: Locally Advanced or Metastatic Melanoma | Phase 1 | Status: COMPLETED